科学图书馆
-
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesSD Wiviott，I Raz，DECLARE–TIMI 58 Investigators. -
Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV TrialF Cosentino , CP Cannon , DZI Cherney et al.
-
Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart FailureKN Bachmann, DK Gupta , M Xu et al.
-
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF RegistriesKi Hong Choi Jin‐Oh Choi et al.
-
The year in cardiology: heart failure: The year in cardiology 2019JGF Cleland, AR Lyon, T McDonagh et al.
-
Mechanical circulatory support devices for acute right ventricular failureKapur NK, Esposito ML, Bader Y et al.
-
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT StudyJanuzzi JL Jr, Richards AM.
-
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of AmericaDunlay SM, Givertz MM, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
